NYSEAMERICAN : STXS
Stereotaxis, Inc. — Financial statements
Healthcare · Medical Instruments & Supplies · United States
Last price 0.8626 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 86.43M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Stereotaxis, Inc. (STXS) reported revenue of 30.07M USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Revenue | 30.07M | 32.38M | 26.92M | 26.77M | 28.15M | 35.02M |
| Cost of Revenue | 13.36M | 15.31M | 12.32M | 11.91M | 9.68M | 11.79M |
| Gross Profit | 16.71M | 17.07M | 14.59M | 14.86M | 18.47M | 23.23M |
| Selling, General & Admin | 26.31M | 28.12M | 27.27M | 26.43M | 26.69M | 25.92M |
| Research & Development | 10.04M | 9.38M | 9.76M | 10.27M | 10.56M | 10.20M |
| Other Operating Expenses | -492.00K | |||||
| Operating Expenses | 36.35M | 37.01M | 37.03M | 36.70M | 37.25M | 36.12M |
| Operating Income | -19.64M | -19.94M | -22.44M | -21.84M | -18.78M | -12.89M |
| Interest Expense | -11.00K | |||||
| Interest & Investment Income | 434.00K | 467.00K | 694.00K | 1.10M | 484.00K | |
| Other Non Operating Income (Expenses) | -2.00K | 2.00K | 30.00K | |||
| EBT Excluding Unusual Items | -19.21M | -19.47M | -21.75M | -20.71M | -18.29M | -12.90M |
| Merger & Restructuring Charges | -500.00K | |||||
| Other Unusual Items | -3.11M | -2.17M | -1.80M | 2.18M | ||
| Pretax Income | -22.32M | -21.64M | -24.05M | -20.71M | -18.29M | -10.72M |
| Net Income | -22.32M | -21.64M | -24.05M | -20.71M | -18.29M | -10.72M |
| Preferred Dividends & Other Adjustments | 1.26M | 1.27M | 1.31M | 1.34M | 1.34M | 1.34M |
| Net Income to Common | -23.59M | -22.91M | -25.35M | -22.06M | -19.64M | -12.06M |
| Shares Outstanding (Basic) | 96.78M | 90.96M | 85.18M | 80.70M | 76.06M | 75.56M |
| Shares Outstanding (Diluted) | 96.78M | 90.96M | 85.18M | 80.70M | 76.06M | 75.56M |
| EPS (Basic) | -0.24 | -0.25 | -0.30 | -0.27 | -0.26 | -0.16 |
| EPS (Diluted) | -0.24 | -0.25 | -0.30 | -0.27 | -0.26 | -0.16 |
| Free Cash Flow | -15.50M | -13.78M | -8.53M | -9.51M | -10.79M | -4.34M |
| Free Cash Flow Per Share | -0.16 | -0.15 | -0.10 | -0.12 | -0.14 | -0.06 |
| Gross Margin | 55.57% | 52.73% | 54.22% | 55.51% | 65.62% | 66.34% |
| Operating Margin | -65.33% | -61.59% | -83.37% | -81.58% | -66.71% | -36.80% |
| Profit Margin | -78.45% | -70.77% | -94.19% | -82.39% | -69.76% | -34.44% |
| Free Cash Flow Margin | -51.56% | -42.55% | -31.69% | -35.50% | -38.34% | -12.40% |
| EBITDA | -18.06M | -18.39M | -21.47M | -21.24M | -18.35M | -12.78M |
| EBITDA Margin | -60.06% | -56.79% | -79.77% | -79.35% | -65.18% | -36.50% |
| D&A For EBITDA | 1.59M | 1.55M | 969.00K | 595.00K | 429.00K | 106.00K |
| EBIT | -19.64M | -19.94M | -22.44M | -21.84M | -18.78M | -12.89M |
| EBIT Margin | -65.33% | -61.59% | -83.37% | -81.58% | -66.71% | -36.80% |
| Revenue as Reported | 30.07M | 32.38M | 26.92M | 26.77M | 28.15M | 35.02M |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 10.49M | 13.42M | 12.22M | 19.82M | 8.59M | 38.74M |
| Short-Term Investments | 19.84M | |||||
| Cash & Short-Term Investments | 10.49M | 13.42M | 12.22M | 19.82M | 28.43M | 38.74M |
| Accounts Receivable | 7.55M | 5.85M | 3.82M | 3.82M | 5.09M | 5.41M |
| Other Receivables | 6.32M | 4.32M | ||||
| Receivables | 13.87M | 10.16M | 3.82M | 3.82M | 5.09M | 5.41M |
| Inventory | 12.52M | 9.57M | 8.33M | 8.43M | 7.88M | 4.43M |
| Prepaid Expenses | 1.11M | 698.00K | 1.85M | 676.00K | 1.32M | 2.36M |
| Restricted Cash | 219.00K | 525.00K | 525.00K | 453.00K | ||
| Total Current Assets | 37.99M | 33.85M | 26.44M | 33.27M | 43.25M | 51.39M |
| Property, Plant & Equipment | 7.54M | 7.93M | 9.06M | 8.29M | 9.21M | 8.37M |
| Goodwill | 3.76M | 3.76M | 3.76M | |||
| Other Intangible Assets | 5.96M | 6.43M | 7.36M | |||
| Other Long-Term Assets | 335.00K | 278.00K | 107.00K | 356.00K | 952.00K | 1.23M |
| Total Assets | 55.58M | 52.25M | 46.72M | 41.91M | 53.41M | 60.98M |
| Accounts Payable | 6.87M | 4.77M | 5.67M | 3.19M | 3.27M | 4.19M |
| Accrued Expenses | 1.32M | 2.06M | 2.92M | 2.97M | 3.14M | 2.29M |
| Current Portion of Leases | 689.00K | 642.00K | 570.00K | 428.00K | 373.00K | 268.00K |
| Current Unearned Revenue | 5.93M | 5.67M | 6.80M | 6.66M | 7.34M | 6.28M |
| Other Current Liabilities | 11.99M | 9.21M | 5.64M | 163.00K | 242.00K | |
| Total Current Liabilities | 26.80M | 22.36M | 21.60M | 13.25M | 14.29M | 13.26M |
| Long-Term Leases | 4.48M | 4.79M | 5.44M | 5.06M | 5.49M | 5.84M |
| Long-Term Unearned Revenue | 384.00K | 555.00K | 2.06M | 1.64M | 1.65M | 2.24M |
| Other Long-Term Liabilities | 6.44M | 5.82M | 6.19M | 43.00K | 51.00K | 218.00K |
| Total Liabilities | 38.10M | 33.53M | 35.29M | 19.99M | 21.48M | 21.56M |
| Common Stock | 98.00K | 95.00K | 85.00K | 81.00K | 75.00K | 75.00K |
| Additional Paid-In Capital | 606.05M | 596.96M | 567.93M | 554.15M | 543.44M | 532.64M |
| Retained Earnings | -593.70M | -583.37M | -561.73M | -537.68M | -516.97M | -498.68M |
| Treasury Stock | -206.00K | -206.00K | -206.00K | -206.00K | -206.00K | -206.00K |
| Total Common Equity | 12.24M | 13.48M | 6.08M | 16.34M | 26.34M | 33.84M |
| Shareholders' Equity | 17.48M | 18.72M | 11.43M | 21.92M | 31.93M | 39.42M |
| Total Liabilities & Equity | 55.58M | 52.25M | 46.72M | 41.91M | 53.41M | 60.98M |
| Total Debt | 5.17M | 5.44M | 6.01M | 5.49M | 5.86M | 6.11M |
| Net Cash (Debt) | 5.32M | 7.99M | 6.21M | 14.33M | 22.57M | 32.63M |
| Net Cash Per Share | 0.05 | 0.09 | 0.07 | 0.18 | 0.30 | 0.43 |
| Filing Date Shares Outstanding | 100.20M | 97.25M | 85.98M | 82.13M | 75.04M | 74.63M |
| Total Common Shares Outstanding | 97.93M | 95.34M | 85.32M | 80.95M | 74.87M | 74.61M |
| Working Capital | 11.19M | 11.49M | 4.84M | 20.02M | 28.95M | 38.12M |
| Book Value Per Share | 0.13 | 0.14 | 0.07 | 0.20 | 0.35 | 0.45 |
| Tangible Book Value | 2.52M | 3.29M | -5.04M | 16.34M | 26.34M | 33.84M |
| Tangible Book Value Per Share | 0.03 | 0.03 | -0.06 | 0.20 | 0.35 | 0.45 |
| Machinery | 5.06M | 4.92M | 5.10M | 4.27M | 4.39M | 3.67M |
| Construction In Progress | 204.00K | 2.16M | ||||
| Leasehold Improvements | 2.93M | 2.92M | 2.92M | 2.91M | 2.69M | 17.00K |
| Order Backlog | 9.10M | 14.40M | 14.70M | 14.80M | 10.10M |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | -22.32M | -21.64M | -24.05M | -20.71M | -18.29M | -10.72M |
| Depreciation & Amortization | 1.59M | 1.55M | 969.00K | 595.00K | 429.00K | 106.00K |
| Loss (Gain) From Sale of Investments | -287.00K | -128.00K | ||||
| Stock-Based Compensation | 8.67M | 9.85M | 10.26M | 10.62M | 10.58M | 9.36M |
| Other Operating Activities | 3.10M | 2.17M | 1.81M | 31.00K | 103.00K | -1.83M |
| Change in Accounts Receivable | -2.08M | -2.02M | 691.00K | 1.27M | 316.00K | -1.89M |
| Change in Inventory | -2.91M | -1.24M | 677.00K | -550.00K | -2.91M | -1.14M |
| Change in Accounts Payable | 62.00K | -880.00K | 758.00K | 218.00K | -169.00K | 1.43M |
| Change in Unearned Revenue | -587.00K | -2.64M | 574.00K | -702.00K | 989.00K | 2.68M |
| Change in Other Net Operating Assets | -811.00K | 1.16M | -195.00K | 378.00K | 667.00K | -953.00K |
| Operating Cash Flow | -15.29M | -13.69M | -8.50M | -9.14M | -8.41M | -2.95M |
| Capital Expenditures | -213.00K | -93.00K | -34.00K | -366.00K | -2.38M | -1.40M |
| Cash Acquisitions | 108.00K | |||||
| Investment in Securities | 20.13M | -19.72M | ||||
| Investing Cash Flow | -1.29M | -93.00K | 74.00K | 19.77M | -22.09M | -1.40M |
| Issuance of Common Stock | 21.21M | 15.66M | 297.00K | 96.00K | 220.00K | 547.00K |
| Other Financing Activities | -1.11M | -893.00K | -15.00K | |||
| Financing Cash Flow | 20.11M | 14.76M | 297.00K | 81.00K | 220.00K | 547.00K |
| Net Cash Flow | 3.52M | 985.00K | -8.13M | 10.71M | -30.29M | -3.80M |
| Free Cash Flow | -15.50M | -13.78M | -8.53M | -9.51M | -10.79M | -4.34M |
| Free Cash Flow Margin | -51.56% | -42.55% | -31.69% | -35.50% | -38.34% | -12.40% |
| Free Cash Flow Per Share | -0.16 | -0.15 | -0.10 | -0.12 | -0.14 | -0.06 |
| Levered Free Cash Flow | -8.83M | -6.67M | 4.61M | -2.53M | -4.35M | -967.29K |
| Unlevered Free Cash Flow | -8.83M | -6.67M | 4.61M | -2.53M | -4.35M | -960.41K |
| Change in Working Capital | -6.32M | -5.62M | 2.50M | 612.00K | -1.10M | 135.00K |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 88.19M | 214.65M | 193.18M | 131.34M | 154.93M | 459.27M |
| Enterprise Value | 82.87M | 214.99M | 194.06M | 120.41M | 135.53M | 431.19M |
| Last Close Price | 0.88 | 2.30 | 2.28 | 1.75 | 2.07 | 6.20 |
| PS Ratio | 2.93 | 6.63 | 7.18 | 4.91 | 5.50 | 13.11 |
| PB Ratio | 7.04 | 11.47 | 16.90 | 5.99 | 4.85 | 11.65 |
| P/TBV Ratio | 34.97 | 65.28 | 8.04 | 5.88 | 13.57 | |
| EV/Sales Ratio | 2.76 | 6.64 | 7.21 | 4.50 | 4.82 | 12.31 |
| Debt / Equity Ratio | 0.30 | 0.29 | 0.53 | 0.25 | 0.18 | 0.15 |
| Net Debt / Equity Ratio | -0.30 | -0.43 | -0.54 | -0.65 | -0.71 | -0.83 |
| Net Debt / EBITDA Ratio | 0.29 | 0.43 | 0.29 | 0.67 | 1.23 | 2.55 |
| Net Debt / FCF Ratio | 0.34 | 0.58 | 0.73 | 1.51 | 2.09 | 7.51 |
| Asset Turnover | 0.62 | 0.65 | 0.61 | 0.56 | 0.49 | 0.60 |
| Inventory Turnover | 1.21 | 1.71 | 1.47 | 1.46 | 1.57 | 3.05 |
| Quick Ratio | 0.91 | 1.05 | 0.74 | 1.78 | 2.35 | 3.33 |
| Current Ratio | 1.42 | 1.51 | 1.22 | 2.51 | 3.03 | 3.88 |
| Return on Equity (ROE) | -184.27% | -143.55% | -144.19% | -76.93% | -51.27% | -26.91% |
| Return on Assets (ROA) | -25.38% | -25.18% | -31.65% | -28.64% | -20.52% | -13.84% |
| Return on Capital Employed (ROCE) | -68.20% | -66.70% | -89.30% | -76.20% | -48.00% | -27.00% |
| Earnings Yield | -27.69% | -10.08% | -12.45% | -15.77% | -11.81% | -2.33% |
| FCF Yield | -17.58% | -6.42% | -4.42% | -7.24% | -6.97% | -0.95% |
| Buyback Yield / Dilution | -11.11% | -6.78% | -5.55% | -6.10% | -0.67% | -3.86% |